Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim R Cressey

Showing results (81-90 of 166) with videos related to

Pageof 17
Sort By:
The Pediatric Infectious Disease Journal|July 17, 2024
Pharmacokinetics of Generic Pediatric Dolutegravir Dispersible Tablet in Thai Young Children Living With HIV Weighing Below Twenty KilogramsAthiporn Rungsapphaiboon, Noppadol Wacharachaisurapol, Suvaporn Anugulruengkitt, et al.
The Journal of Antimicrobial Chemotherapy|February 25, 2025
Validation of the REverSe TRanscrIptase Chain Termination assay for measuring tenofovir diphosphate in dried blood spots from a clinical pharmacokinetic trialBenjamin P Sullivan, Cosette A Craig, Andrew T Bender, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 22, 2019
Brief Report: Validation of a Urine Tenofovir Immunoassay for Adherence Monitoring to PrEP and ART and Establishing the Cutoff for a Point-of-Care TestMonica Gandhi, Peter Bacchetti, Matthew A Spinelli, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 12, 2018
Optimizing Clinical Trial Design to Maximize Evidence Generation in Pediatric HIVDeborah Ford, Rebecca Turner, Anna Turkova, et al.
BMC Infectious Diseases|July 15, 2017
A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: the TARGET studyTim R Cressey, Oraphan Siriprakaisil, Virat Klinbuayaem, et al.
Antimicrobial Agents and Chemotherapy|February 25, 2009
Early postpartum pharmacokinetics of lopinavir initiated intrapartum in Thai womenTim R Cressey, Russell Van Dyke, Gonzague Jourdain, et al.
The Journal of Antimicrobial Chemotherapy|September 28, 2014
Impact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancyTim R Cressey, Saik Urien, Edmund V Capparelli, et al.
The Pediatric Infectious Disease Journal|July 31, 2015
Efavirenz Concentrations and Probability of HIV Replication in ChildrenNontiya Homkham, Tim R Cressey, Naïm Bouazza, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 20, 2025
Single Doses of Pediatric Dolutegravir Dispersible Tablets in Neonates Support Multidosing: PETITE-Dolutegravir StudyTim R Cressey, Nicolas Salvadori, Helena Rabie, et al.
Clinical Pharmacokinetics|February 2, 2021
Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and RaltegravirXiaomei I Liu, Jeremiah D Momper, Natella Y Rakhmanina, et al.
Pageof 17

Showing results (81-90 of 166) with videos related to

Sort By:
Pageof 17
The Pediatric Infectious Disease Journal|July 17, 2024
Pharmacokinetics of Generic Pediatric Dolutegravir Dispersible Tablet in Thai Young Children Living With HIV Weighing Below Twenty KilogramsAthiporn Rungsapphaiboon, Noppadol Wacharachaisurapol, Suvaporn Anugulruengkitt, et al.
The Journal of Antimicrobial Chemotherapy|February 25, 2025
Validation of the REverSe TRanscrIptase Chain Termination assay for measuring tenofovir diphosphate in dried blood spots from a clinical pharmacokinetic trialBenjamin P Sullivan, Cosette A Craig, Andrew T Bender, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 22, 2019
Brief Report: Validation of a Urine Tenofovir Immunoassay for Adherence Monitoring to PrEP and ART and Establishing the Cutoff for a Point-of-Care TestMonica Gandhi, Peter Bacchetti, Matthew A Spinelli, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 12, 2018
Optimizing Clinical Trial Design to Maximize Evidence Generation in Pediatric HIVDeborah Ford, Rebecca Turner, Anna Turkova, et al.
BMC Infectious Diseases|July 15, 2017
A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: the TARGET studyTim R Cressey, Oraphan Siriprakaisil, Virat Klinbuayaem, et al.
Antimicrobial Agents and Chemotherapy|February 25, 2009
Early postpartum pharmacokinetics of lopinavir initiated intrapartum in Thai womenTim R Cressey, Russell Van Dyke, Gonzague Jourdain, et al.
The Journal of Antimicrobial Chemotherapy|September 28, 2014
Impact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancyTim R Cressey, Saik Urien, Edmund V Capparelli, et al.
The Pediatric Infectious Disease Journal|July 31, 2015
Efavirenz Concentrations and Probability of HIV Replication in ChildrenNontiya Homkham, Tim R Cressey, Naïm Bouazza, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 20, 2025
Single Doses of Pediatric Dolutegravir Dispersible Tablets in Neonates Support Multidosing: PETITE-Dolutegravir StudyTim R Cressey, Nicolas Salvadori, Helena Rabie, et al.
Clinical Pharmacokinetics|February 2, 2021
Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and RaltegravirXiaomei I Liu, Jeremiah D Momper, Natella Y Rakhmanina, et al.
Pageof 17